Crystal Diagnostics
PrivateCompany Overview
Crystal Diagnostics is a biotechnology company that provides rapid pathogen detection technology for the food safety industry using a patented liquid crystal platform.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Quality Management, Sensors, Environmental Monitoring
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Crystal Diagnostics Comparables
Compare Crystal Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SnapDNA | 79% | |
| NEMIS Technologies | 77% | |
| PathogenDx | 76% | |
Crystal Diagnostics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 9, 2025
Grew 40% QoQ, from 25 to 35 employees.
- Jan 14, 2025
Grew 28% QoQ, from 25 to 32 employees.
Crystal Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Crystal Diagnostics's valuation, stock price, and market status.